Fuan Pharmaceutical: Notice on Subsidiaries Receiving Drug Registration Certificates
Fuan Pharmaceutical: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024
Fuan Pharmaceutical: Notice on Increasing Cash Management Quota for Idle Own Funds
Fuan Pharmaceutical: Announcement regarding subsidiary passing on-site inspection by USA FDA.
Fuan Pharmaceutical: Announcement on Subsidiary's Receipt of Approval Letter for Supplementary Application of Pharmaceutical
Fuan Pharmaceutical: Announcement on Subsidiary's Receipt of Approval Letter for Supplementary Application of Pharmaceutical
Fuan Pharmaceutical: Announcement Regarding Subsidiary Receiving Pharmaceutical Registration Certificate.
Fuan Pharmaceutical: Announcement Regarding Subsidiary Receiving Pharmaceutical Registration Certificate.
Fuan Pharmaceutical: Announcement regarding the subsidiary receiving notification of approval for the listing application of chemical raw materials.
Fuan Pharmaceutical: Announcement on Subsidiary's Receipt of Approval Letter for Supplementary Application of Pharmaceutical
Fuan Pharmaceutical: Announcement Regarding Subsidiary Receiving Pharmaceutical Registration Certificate.
Fuan Pharmaceutical: Announcement regarding the subsidiary receiving notification of approval for the listing application of chemical raw materials.
Fuan Pharmaceutical: Notice on the subsidiary receiving the drug registration certificate
Fuan Pharmaceutical: Oriental Huayin's Legal Opinion on the 2023 Annual General Meeting of Shareholders of Fuan Pharmaceutical
Fuan Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Fuan Pharmaceutical: Notice on Subsidiaries Receiving Approval Notice for Drug Supplementation Applications
Fuan Pharmaceutical: Notice on the subsidiary's withdrawal of drug registration applications
Fuan Pharmaceutical: Notice on the subsidiary receiving the drug registration certificate
Fuan Pharmaceutical: Notice on Using Idle Own Funds for Cash Management
Fuan Pharmaceutical: 2023 Financial Results Report
No Data
No Data